GlaxoSmithKline is going to announce more than 3,000 job cuts, reports the Financial Times, though the UK’s Times Online put that number closer to 4,000. The Times says the losses will be in Europe and the US and are “part of [the company’s] plans to restructure its workforce and focus increasingly on emerging markets.” The changes will affect administration, manufacturing, sales, and research staff, the Financial Times adds.
If made, this announcement will come on the heels of AstraZeneca's plan to cut 8,000 jobs.